...
首页> 外文期刊>American journal of medical genetics, Part A >Characterization of fat distribution in Prader-Willi syndrome: relationships with adipocytokines and influence of growth hormone treatment.
【24h】

Characterization of fat distribution in Prader-Willi syndrome: relationships with adipocytokines and influence of growth hormone treatment.

机译:Prader-Willi综合征中脂肪分布的特征:与脂肪细胞因子的关系和生长激素治疗的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

Marked anthropometric changes are seen in Prader-Willi syndrome (PWS). Emaciation is observed during infancy, whereas severe obesity is found in older children and adults. Growth hormone (GH) treatment modifies the anthropometric changes in PWS patients. In this study, we examined changes in the body composition of 51 PWS patients (age range, 6-54 years; median, 16.5 years), with a focus on the amount of abdominal visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT), VAT/SAT ratio, and serum levels of adipocytokines (adiponectin, leptin, and resistin). The relationships between VAT, SAT, and adipocytokines, and lipid abnormalities and type 2 diabetes in 24 patients with obese PWS were also evaluated. With increasing age, SAT and VAT both increased markedly, but in 18 patients receiving GH treatment, VAT remained low at ≤30?cm(2) . In the GH-completed patients (n?=?19), VAT and SAT increased with age to levels similar to those in non-GH-treated patients (n?=?14). In the obese group, adiponectin decreased as VAT increased (r?=?-0.35, P?=?0.11). Leptin (r?=?0.67, P?
机译:在Prader-Willi综合征(PWS)中可以看到明显的人体测量学变化。在婴儿期观察到消瘦,而在较大的儿童和成人中发现严重肥胖。生长激素(GH)治疗可改善PWS患者的人体测量学变化。在这项研究中,我们检查了51名PWS患者(年龄范围为6-54岁;中位数为16.5岁)的身体组成变化,重点是腹部内脏脂肪组织(VAT)和皮下脂肪组织(SAT)的数量),VAT / SAT比值和血清脂细胞因子(脂联素,瘦素和抵抗素)水平。还评估了24例肥胖PWS患者中VAT,SAT和脂肪细胞因子与脂质异常和2型糖尿病之间的关系。随着年龄的增长,SAT和VAT均显着增加,但是在接受GH治疗的18例患者中,VAT仍保持在≤30?cm(2)的较低水平。在完成GH的患者中(n?=?19),VAT和SAT随着年龄的增长而增加,达到与未进行GH治疗的患者相似的水平(n?=?14)。在肥胖组中,脂联素随着增值税的增加而降低(r ==-0.35,P == 0.11)。瘦素(r = 0.67,P <0.001)和抵抗素(r = 0.45,P = 0.04)与SAT呈正相关。总胆固醇,低密度脂蛋白和甘油三酸酯水平与脂联素呈负相关(分别为r?=?-0.59,r?=?-0.56,r?=?-0.56,P?<?0.05)和血红蛋白A1c(r α=α-0.42,Pα=α0.08)。为了维持较低的增值税并预防心血管疾病的危险因素,即使在成年PWS患者中也建议进行GH治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号